Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yvette E. Latchman
Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
839 Dual Targeting Autoinflammation and PD-L1/L2 Immune Checkpoint by EGCG Augments Anti-Tumor Effects in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma
New England Journal of Medicine
Medicine
Regorafenib Promotes Anti-Tumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma
Clinical Cancer Research
Cancer Research
Oncology
FcγRs Modulate the Anti-Tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
Cancer Cell
Cancer Research
Oncology
Cell Biology
PD-L1 Expression by Tumor Cell-Lines: A Predictive Marker in Melanoma
Experimental Dermatology
Biochemistry
Dermatology
Molecular Biology
Targeting the PD1/PD-L1 Axis in Melanoma: Biological Rationale, Clinical Challenges and Opportunities
Critical Reviews in Oncology/Hematology
Gerontology
Geriatrics
Hematology
Oncology
PD-L1-specific Helper T-Cells Exhibit Effective Antitumor Responses: New Strategy of Cancer Immunotherapy Targeting PD-L1 in Head and Neck Squamous Cell Carcinoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Anti-Pd-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
Cancer Research
Cancer Research
Oncology
Elimination of Tumor by CD47/PD-L1 Dual-Targeting Fusion Protein That Engages Innate and Adaptive Immune Responses
mAbs
Allergy
Immunology